[Model for acquired immunodeficiency caused by anesthesia and surgical procedures. Effect of treatment with thymopoietin pentapeptide (TP5)].
D000293:Adolescent; D000328:Adult; D000758:Anesthesia / Q000009:adverse effects*; D000917:Antibody Formation; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy / Q000209:etiology*; D008875:Middle Aged; D008954:Models, Biological; D010446:Peptide Fragments / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy / Q000209:etiology*; D016305:Thymopentin; D013946:Thymopoietins / Q000627:therapeutic use*; D013951:Thymus Hormones / Q000627:therapeutic use*
D010446:Peptide Fragments; D013946:Thymopoietins; D013951:Thymus Hormones; D016305:Thymopentin
Modello di immunodeficienza acquisita da anestesia e procedure chirurgiche. Influenza di un trattamento con Timopoietina pentapeptide (TP5).